rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.47360/1995-4484-2025-129-137rsp-3722Research ArticleМЕЖДУНАРОДНЫЕ И РОССИЙСКИЕ РЕКОМЕНДАЦИИ ПО ЛЕЧЕНИЮ РЕВМАТИЧЕСКИХ ЗАБОЛЕВАНИЙINTERNATIONAL AND RUSSIAN GUIDELINES FOR THE TREATMENT OF RHEUMATIC DISEASESРекомендации по лечению аксиального спондилоартрита: анализ обновленных клинических рекомендаций ASAS/EULAR 2022 годаRecommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelineshttps://orcid.org/0000-0002-1771-6246ДубининаТ. В.ErdesSh. F.

Дубинина Татьяна Васильевна

115522, Москва, Каширское шоссе, 34а

Shandor F. Erdes

115522, Moscow, Kashirskoye Highway, 34A

tatiana-dubinina@mail.ruhttps://orcid.org/0000-0003-3195-5187ЭрдесШ. Ф.DubininaT. V.

115522, Москва, Каширское шоссе, 34а

Tatiana V. Dubinina

115522, Moscow, Kashirskoye Highway, 34A

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian Federation202501052025632129137Copyright © Дубинина Т.В., Эрдес Ш.Ф., 20252025Дубинина Т.В., Эрдес Ш.Ф.Erdes S.F., Dubinina T.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/3722

В статье обсуждается обновленная в 2022 г. версия рекомендаций по лечению аксиального спондилоартрита, разработанных совместно Международным обществом по изучению спондилоартритов (ASAS, Assessment in SpondyloArthritis international Society) и Европейским альянсом ревматологических ассоциаций (EULAR, European Alliance of Associations for Rheumatology).

The article discusses the 2022 updated version of the collaborative ASAS/EULAR (Assessment in SpondyloArthritis international Society/European Alliance of Associations for Rheumatology) recommendations for the treatment of axial spondyloarthritis.

клинические рекомендацииаксиальный спондилоартритгенно-инженерная биологическая терапияингибиторы фактора некроза опухоли альфаингибиторы интерлейкина 17ингибиторы Янус-киназclinical guidelinesaxial spondyloarthritisbiological therapyinhibitors of tumor necrosis factor alphainterleukin 17 inhibitorsJanus kinase inhibitorsReferencesФедеральный закон от 25.12.2018 № 489-ФЗ «О внесении изменений в статью 40 Федерального закона «Об обязательном медицинском страховании в Российской Федерации» и Федеральный закон «Об основах охраны здоровья граждан в Российской Федерации» по вопросам клинических рекомендаций». URL: https://publication.pravo.gov.ru/Document/View/0001201812250098 (Accessed: 21st January 2025).Federal Law No. 489-FZ dated 25.12.2018 “On the amendments to Article 40 of the Federal Law “On compulsory medical insurance in the Russian Federation” and the Federal Law “On the fundamentals of health protection of citizens in the Russian Federation” on issues of clinical guidelines” (In Russ.). URL: https://publication.pravo.gov.ru/Document/View/0001201812250098 (Accessed: 21st January 2025).Об охране здоровья граждан в Российской Федерации: Подборка наиболее важных документов по запросу «Об охране здоровья граждан в Российской Федерации» (нормативноправовые акты, формы, статьи, консультации экспертов и многое другое). URL: https://www.consultant.ru/law/podborki/ob_ohrane_zdorovya_grazhdan_v_rossijskoj_federacii/ (Accessed: 21st January 2025).On the protection of citizens’ health in the Russian Federation: A selection of the most important documents for the request “On the protection of citizens’ health in the Russian Federation” (regulatory legal acts, forms, articles, expert consultations and much more) (In Russ.). URL: https:// www.consultant.ru/law/podborki/ob_ohrane_zdorovya_grazhdan_v_rossijskoj_federacii/ (Accessed: 21st January 2025).Малюгин СВ, Винокурова АА. Клинические рекомендации в системе регламентации оказания медицинской помощи в современной России: теоретическое представление и практические аспекты. Lex Russica. 2023;76(7):28-47. doi: 10.17803/1729-5920.2023.200.7.028-047Malyugin SV, Vinokurova AA. Clinical guidelines in the system of medical care in modern Russia: Theoretical statement and practical aspects. Lex Russica. 2023;76(7):28-47 (In Russ.). doi: 10.17803/1729-5920.2023.200.7.028-047Андреева ИВ, Стецюк ОУ, Егорова ОА. Клинические рекомендации: что нужно знать практикующему врачу. РМЖ. 2020;5:21-25.Andreeva IV, Stetsyuk OU, Egorova OA. Clinical guidelines: What the practitioner should know? RMJ. 2020;5:21-25 (In Russ.).Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi: 10.1136/ard.2009.108233Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi: 10.1136/ard.2009.108233van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361-368. doi: 10.1002/art.1780270401van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361-368. doi: 10.1002/art.1780270401van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, et al. 2016 update of the ASASEULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, et al. 2016 update of the ASASEULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19-34. doi: 10.1136/ard-2022-223296Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19-34. doi: 10.1136/ard-2022-223296Choufani M, Kay J, Ermann J. Axial spondyloarthritis guidelines – aiming for maximum impact. Curr Opin Rheumatol. 2024;36(4):251-260. doi: 10.1097/BOR.0000000000001020Choufani M, Kay J, Ermann J. Axial spondyloarthritis guidelines – aiming for maximum impact. Curr Opin Rheumatol. 2024;36(4):251-260. doi: 10.1097/BOR.0000000000001020van der Heijde D, Aletaha D, Carmona L, Edwards CJ, Kvien TK, Kouloumas M, et al. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Ann Rheum Dis. 2015;74(1):8-13. doi: 10.1136/annrheumdis-2014-206350van der Heijde D, Aletaha D, Carmona L, Edwards CJ, Kvien TK, Kouloumas M, et al. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Ann Rheum Dis. 2015;74(1):8-13. doi: 10.1136/annrheumdis-2014-206350Seo MR, Yeo J, Park JW, Lee YA, Lee JH, Kang EH, et al.; Korean Society of Spondyloarthritis Research. Korean treatment recommendations for patients with axial spondyloarthritis. Korean J Intern Med. 2024;39(1):200. doi: 10.3904/kjim.2023.194.e1Seo MR, Yeo J, Park JW, Lee YA, Lee JH, Kang EH, et al.; Korean Society of Spondyloarthritis Research. Korean treatment recommendations for patients with axial spondyloarthritis. Korean J Intern Med. 2024;39(1):200. doi: 10.3904/kjim.2023.194.e1Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis. 2014;73(8):1455-1461. doi: 10.1136/annrheumdis-2014-205178Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis. 2014;73(8):1455-1461. doi: 10.1136/annrheumdis-2014-205178Подряднова МВ, Балабанова РМ, Урумова ММ, Эрдес ШФ. Взаимосвязь клинических характеристик анкилозирующего спондилита с трудоспособностью и производительностью труда. Научно-практическая ревматология. 2014;52(5):513-519. doi: 10.14412/1995-4484-2014-513-519Podryadnova MV, Balabanova RM, Urumova MM, Erdes ShF. Correlation between clinical characteristics of ankylosing spondylitis and work capacity and productivity. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014;52(5):513-519 (In Russ.). doi: 10.14412/1995-4484-2014-513-519Ramonda R, Marchesoni A, Carletto A, Bianchi G, Cutolo M, Ferraccioli G, et al.; ATLANTIS study group. Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey. Arthritis Res Ther. 2016;18:78. doi: 10.1186/s13075-016-0977-2Ramonda R, Marchesoni A, Carletto A, Bianchi G, Cutolo M, Ferraccioli G, et al.; ATLANTIS study group. Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey. Arthritis Res Ther. 2016;18:78. doi: 10.1186/s13075-016-0977-2Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68(6):784-788. doi: 10.1136/ard.2008.101501Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68(6):784-788. doi: 10.1136/ard.2008.101501Webers C, Nezam El-Din R, Beckers E, Been M, Vonkeman HE, van Tubergen A. Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice. Rheumatology (Oxford). 2025;64(1):91-98. doi: 10.1093/rheumatology/kead634Webers C, Nezam El-Din R, Beckers E, Been M, Vonkeman HE, van Tubergen A. Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice. Rheumatology (Oxford). 2025;64(1):91-98. doi: 10.1093/rheumatology/kead634Bolt JW, Aalbers CJ, Walet L, van Mens LJJ, van Denderen C, van der Horst-Bruinsma I, et al. Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target. Rheumatology (Oxford). 2024;63(1):34-40. doi: 10.1093/rheumatology/kead155Bolt JW, Aalbers CJ, Walet L, van Mens LJJ, van Denderen C, van der Horst-Bruinsma I, et al. Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target. Rheumatology (Oxford). 2024;63(1):34-40. doi: 10.1093/rheumatology/kead155Desthieux C, Molto A, Granger B, Saraux A, Fautrel B, Gossec L. Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: The DESIR cohort. Ann Rheum Dis. 2016;75(9):1661-1666. doi: 10.1136/annrheumdis-2015-208251Desthieux C, Molto A, Granger B, Saraux A, Fautrel B, Gossec L. Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: The DESIR cohort. Ann Rheum Dis. 2016;75(9):1661-1666. doi: 10.1136/annrheumdis-2015-208251Feldtkeller E, Rudwaleit M, Zeidler H. Easy probability estimation of the diagnosis of early axial spondyloarthritis by summing up scores. Rheumatology (Oxford). 2013;52(9):1648-1650. doi: 10.1093/rheumatology/ket176Feldtkeller E, Rudwaleit M, Zeidler H. Easy probability estimation of the diagnosis of early axial spondyloarthritis by summing up scores. Rheumatology (Oxford). 2013;52(9):1648-1650. doi: 10.1093/rheumatology/ket176Wendling D, Lukas C, Paccou J, Claudepierre P, Carton L, Combe B, et al.; French Society for Rheumatology (SFR). Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis. Joint Bone Spine. 2014;81(1):6-14. doi: 10.1016/j.jbspin.2013.12.002Wendling D, Lukas C, Paccou J, Claudepierre P, Carton L, Combe B, et al.; French Society for Rheumatology (SFR). Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis. Joint Bone Spine. 2014;81(1):6-14. doi: 10.1016/j.jbspin.2013.12.002Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: Recommendations of an international task force. Ann Rheum Dis. 2014;73(1):6-16. doi: 10.1136/annrheumdis-2013-203419Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: Recommendations of an international task force. Ann Rheum Dis. 2014;73(1):6-16. doi: 10.1136/annrheumdis-2013-203419Wendling D, Prati C, Sieper J. Disease activity in ankylosing spondylitis: The global therapeutic target. Ann Rheum Dis. 2018;77(8):1095-1096. doi: 10.1136/annrheumdis-2017-212363Wendling D, Prati C, Sieper J. Disease activity in ankylosing spondylitis: The global therapeutic target. Ann Rheum Dis. 2018;77(8):1095-1096. doi: 10.1136/annrheumdis-2017-212363Ortolan A, Webers C, Sepriano A, Falzon L, Baraliakos X, Landewé RB, et al. Efficacy and safety of non-pharmacological and non-biological interventions: A systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis. 2023;82(1):142-152. doi: 10.1136/ard-2022-223297Ortolan A, Webers C, Sepriano A, Falzon L, Baraliakos X, Landewé RB, et al. Efficacy and safety of non-pharmacological and non-biological interventions: A systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis. 2023;82(1):142-152. doi: 10.1136/ard-2022-223297Rodríguez-Lozano C, Juanola X, Cruz-Martínez J, Peña-Arrébola A, Mulero J, Gratacós J, et al.; Spondyloarthropathies Study Group of the Spanish Society of Rheumatology. Outcome of an education and home-based exercise programme for patients with ankylosing spondylitis: A nationwide randomized study. Clin Exp Rheumatol. 2013;31(5):739-748Rodríguez-Lozano C, Juanola X, Cruz-Martínez J, Peña-Arrébola A, Mulero J, Gratacós J, et al.; Spondyloarthropathies Study Group of the Spanish Society of Rheumatology. Outcome of an education and home-based exercise programme for patients with ankylosing spondylitis: A nationwide randomized study. Clin Exp Rheumatol. 2013;31(5):739-748Braun J, Baraliakos X, Westhoff T. Nonsteroidal anti-inflammatory drugs and cardiovascular risk – a matter of indication. Semin Arthritis Rheum. 2020;50(2):285-288. doi: 10.1016/j.semarthrit.2019.07.012Braun J, Baraliakos X, Westhoff T. Nonsteroidal anti-inflammatory drugs and cardiovascular risk – a matter of indication. Semin Arthritis Rheum. 2020;50(2):285-288. doi: 10.1016/j.semarthrit.2019.07.012Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68(2):282-298. doi: 10.1002/art.39298Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68(2):282-298. doi: 10.1002/art.39298Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71(10):1285-1299. doi: 10.1002/acr.24025Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71(10):1285-1299. doi: 10.1002/acr.24025

The authors declare that there are no conflicts of interest present.